VR
Highly rated in
2
conditions
Highly rated in
2
conditions

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

About Dr. Voa Ratsimbazafy

Voa Ratsimbazafy is in Limoges, France. Dr. Ratsimbazafy is highly rated in 2 conditions, according to our data. Their top areas of expertise are Caffey Disease, Epilepsy, Seizures, and Cysticercosis.

Their clinical research consists of co-authoring 25 peer reviewed articles in the past 15 years.

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Locations
  Limoges, 87000, FR
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Limoges University Hospital
 
Limoges, FR 87000
 0.1 km
Eric Liozon is in Limoges, France. They have been an author on 64 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
Centre Hospitalier Universitaire De Limoges
 
Limoges, FR 
 0.1 km
Arnaud Jaccard is in Limoges, France. They have been an author on 139 peer reviewed articles and participated in 10 clinical trials in the past 15 years.
Highly rated in
0
conditions
Centre Hospitalier Universitaire De Poitiers
 
Limoges, FR 87000
 0.1 km
Frank Bridoux is in Limoges, France. They have been an author on 132 peer reviewed articles and participated in 1 clinical trial in the past 15 years.